Literature DB >> 3480506

Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids.

W C Forrester1, S Takegawa, T Papayannopoulou, G Stamatoyannopoulos, M Groudine.   

Abstract

We have analyzed the chromatin structure of the human beta-globin locus in somatic cell hybrids resulting from the fusion of human non-erythroid cells and mouse erythroleukemia (MEL) cells. In these hybrids, the human adult beta-globin gene, but neither the embryonic nor fetal globin genes, is activated transcriptionally. In addition, the DNase I-resistant beta-like globin locus characteristic of the parental non-erythroid human cells (1,2) is reorganized over an approximately 80 kb region, including the formation of the developmentally stable hypersensitive sites 50 kb 5' and 20 kg 3' of the activated adult beta-globin gene (2,3). These results are consistent with the hypothesis that events occurring at the 5' and/or 3' developmentally stable hypersensitive sites are important, if not necessary, for the activation of the beta-globin locus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3480506      PMCID: PMC339937          DOI: 10.1093/nar/15.24.10159

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.

Authors:  H P Koeffler; D W Golde
Journal:  Science       Date:  1978-06-09       Impact factor: 47.728

2.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

3.  DNA restriction endonuclease analysis for localization of human beta- and delta-globin genes on chromosome 11.

Authors:  A F Scott; J A Phillips; B R Migeon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  K562--a human erythroleukemic cell line.

Authors:  L C Andersson; K Nilsson; C G Gahmberg
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

5.  Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.

Authors:  C Friend; W Scher; J G Holland; T Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

6.  The primary structure of the human epsilon-globin gene.

Authors:  F E Baralle; C C Shoulders; N J Proudfoot
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

7.  The 5' flanking region of human epsilon-globin gene.

Authors:  F E Baralle; C C Shoulders; S Goodbourn; A Jeffreys; N J Proudfoot
Journal:  Nucleic Acids Res       Date:  1980-10-10       Impact factor: 16.971

8.  The 5' ends of Drosophila heat shock genes in chromatin are hypersensitive to DNase I.

Authors:  C Wu
Journal:  Nature       Date:  1980-08-28       Impact factor: 49.962

9.  The human beta-globin gene contains a downstream developmental specific enhancer.

Authors:  G Kollias; J Hurst; E deBoer; F Grosveld
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

Review 10.  Human myeloid leukemia cell lines: a review.

Authors:  H P Koeffler; D W Golde
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

View more
  159 in total

1.  Reconstitution of human beta-globin locus control region hypersensitive sites in the absence of chromatin assembly.

Authors:  K M Leach; K Nightingale; K Igarashi; P P Levings; J D Engel; P B Becker; J Bungert
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 2.  Gene therapy for the hemoglobin disorders: past, present, and future.

Authors:  D A Persons; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Nrf2 is essential for protection against acute pulmonary injury in mice.

Authors:  K Chan; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Patterns of histone acetylation suggest dual pathways for gene activation by a bifunctional locus control region.

Authors:  F Elefant; Y Su; S A Liebhaber; N E Cooke
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

5.  Generation of stable recombinant retroviruses containing the beta-globin genes linked to complex regulatory elements by using transient transfection.

Authors:  B Li; D Liu; J Wang; W Dong; C C Liang
Journal:  Mol Biotechnol       Date:  1999-11       Impact factor: 2.695

6.  The developmental activation of the chicken lysozyme locus in transgenic mice requires the interaction of a subset of enhancer elements with the promoter.

Authors:  M C Huber; U Jägle; G Krüger; C Bonifer
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

7.  The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression.

Authors:  J Liu; D Bramblett; Q Zhu; M Lozano; R Kobayashi; S R Ross; J P Dudley
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

8.  An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer.

Authors:  Osamu Tanabe; Fumiki Katsuoka; Andrew D Campbell; Weimin Song; Masayuki Yamamoto; Keiji Tanimoto; James Douglas Engel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

9.  The ERV-9 LTR enhancer is not blocked by the HS5 insulator and synthesizes through the HS5 site non-coding, long RNAs that regulate LTR enhancer function.

Authors:  Jianhua Ling; Wenhu Pi; Xiuping Yu; Chikh Bengra; Qiaoming Long; Huaqian Jin; Andreas Seyfang; Dorothy Tuan
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

10.  Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression.

Authors:  J J Caterina; D Donze; C W Sun; D J Ciavatta; T M Townes
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.